Description
Abiraterone Acetate is a prescription oral tablet with 250 mg of the active ingredient, used to treat metastatic castration-resistant prostate cancer in men. It's a generic version manufactured by Rising Pharma Holdings, Inc., approved under ANDA208371. This information was generated using AI and is provided for informational and research purposes only.
Resources
| Name | Format | Description | Link |
|---|---|---|---|
| Abiraterone acetate | HTML | Access the FDA dataset for Abiraterone acetate — ANDA 210308 submitted by Mylan Institutional LLC | Open resource |